KELSEY BEASLEY: Open Payments
NPI 1003325952 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 117 payments from 39 companies in 2025. Trend: 2023 $1,753 · 2024 $2,378 · 2025 $2,455
Food & beverage: $2,455
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $347 |
| Janssen Biotech, Inc. | 11 | $182 |
| ABBVIE INC. | 6 | $130 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| Incyte Corporation | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| JAZZ PHARMACEUTICALS INC. | 3 | $83 |
Products named: Nubeqa, KISQALI, OPDIVO, KEYTRUDA, RYBREVANT, Fabhalta, PLUVICTO, ZEPZELCA.
Industry payments across IL — which companies pay providers there.
